Enfusion Q4 2023 Adj EPS $0.04 Misses $0.05 Estimate, Sales $46.486M Beat $45.275M Estimate
Author: Benzinga Newsdesk | March 12, 2024 08:05am
Enfusion (NYSE:
ENFN) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.05 by 20 percent. The company reported quarterly sales of $46.486 million which beat the analyst consensus estimate of $45.275 million by 2.67 percent. This is a 14.73 percent increase over sales of $40.517 million the same period last year.
Posted In: ENFN